Overview
In March of 2021, Puff Bar re-entered the US vape market with its disposable e-cigarettes, claiming that since their products contain synthetic nicotine instead of tobacco-derived nicotine, they fall outside of FDA’s regulatory authority. Many other companies have followed suit, and synthetic nicotine products are rising in popularity while FDA’s Center for Tobacco Products (CTP) attempts to rein in the market for tobacco-derived nicotine products. The webinar will begin with a scientific review of synthetic nicotine, including how it is made, how testing can distinguish it from tobacco-derived nicotine, and whether it poses its own unique health concerns. Following that review, the webinar will discuss perspectives on FDA’s authority to regulate these products and consider potential regulatory approaches at the federal, state, and local levels.
Get Access
- +$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Speakers
Kevin Burd, Chief Executive Officer, Chemular, Inc. and Chief Executive Officer, North American Nicotine
Bonnie Coffa, Business Development Manager, Enthalpy Analytical
Kathleen Hoke, Law School Professor and Director, Network for Public Health Law Eastern Region, Francis King Carey School of Law, University of Maryland
Eric N. Lindblom, Independent Consultant and Senior Scholar, O’Neill Institute, Georgetown Law Center
Moderated by Kenneth Michael Cummings, Professor, Medical University of South Carolina
KATHLEEN HOKE is a Law School Professor, Director of the Legal Resource Center for Public Health Policy, and Director of the Network for Public Health Law-Eastern Region, at the University of Maryland Carey School of Law. Through the Center and Network, Kathleen provides technical legal assistance to state and local health officials, legislators, researchers, and organizations working to use law and policy change to improve public health. With the Legal Resource Center, Kathleen supports Maryland policymakers, legislators, public health officials, and community organizations work through myriad legal issues related to tobacco control and prevention, regulation of gambling, and injury prevention. As a Professor at Maryland Carey Law for nearly two decades, Kathleen directs the Public Health Law Clinic and teaches Public Health and the Law and Legal Analysis and Writing. Kathleen’s interdisciplinary work has resulted in co-authored publications across the spectrum, including in the Journal of Law, Medicine and Ethics; Injury Prevention; Journal of Urban Health; Journal of Health Care Law and Policy; and the Journal of Health Care for the Poor and Underserved. Kathleen was given the UMB President’s Award for Excellence in 2020 and in 2016 received the Jennifer Robbins Award for the Practice of Public Health Law by the American Public Health Association Law Section. In 2020, Kathleen accepted a position on the editorial board of the CDC’s publication, Preventing Chronic Disease. She serves a variety of professional organizations and has been appointed by Maryland’s Governor to the Maryland State Council on Cancer Control. Kathleen graduated as a member of the Order of the Coif from the University of Maryland School of Law in 1992, completed a clerkship with the Honorable Lawrence Rodowsky of the Maryland Court of Appeals and served with distinction as an Assistant Attorney General and Special Assistant to the Attorney General of Maryland prior to joining the School of Law in 2002.
ERIC N. LINDBLOM is an independent legal and policy consultant on the regulation of tobacco products and legalized cannabis products and a Senior Scholar at Georgetown Law’s O’Neill Institute for National and Global Health Law, where he previously served as Director for Tobacco Control and Food & Drug Law. Before joining the O’Neill Institute, Mr. Lindblom was Director of the Office of Policy at the FDA Center for Tobacco Products and a member of CTP’s leadership team from 2011 to 2014. Prior to that, Mr. Lindblom served as General Counsel and Director for Policy Research at the Campaign for Tobacco-Free Kids, and previously held positions with the federal government, a member of Congress, political campaigns, a law firm, and nonprofit advocacy organizations. Mr. Lindblom has a J.D. from Harvard Law School and a B.A. in Political Science from Yale University. Some of Mr. Lindblom’s publications are available online via 
KENNETH MICHAEL CUMMINGS is a professor in the Department of Psychiatry & Behavioral Sciences and member of the Hollings Cancer Center’s Cancer Control Program at the Medical University of South Carolina where he co-leads the tobacco control research program. He is widely recognized for his research on smoking behavior, product marketing, consumer risk perceptions, and the influence of cigarette design on smoking behavior. Dr. Cummings has authored over 540 peer-reviewed scientific papers as well as contributing to reports for the Office of the Surgeon General, the National Cancer Institute, the Institute of Medicine, and the International Agency for Research on Cancer. In the late 1990s, Dr. Cummings was involved in digitizing and indexing millions of pages of previously secret internal tobacco industry documents which have helped to uncover how cigarette manufacturers directed their marketing to attract youthful replacement smokers and designed cigarettes in ways that make it hard for smokers to quit once they get addicted to nicotine. He has served as an expert witness in litigation against cigarette manufacturers in over 200 trials spanning 25 years and has received numerous awards acknowledging his research contributions to public health and tobacco control include the American Cancer Society’s prestigious Luther Terry Award and more recently the Alton Ochsner for outstanding research in tobacco control.Virtual Learning FAQ
Related Content
